OM: Aguerd Operational, Genesio Nevertheless Confirms A Gradual Return

Nayef Aguerd has cleared the final medical hurdle in his long road back to competitive football. Bruno Genesio confirmed that the Moroccan defender is now officially operational, ending a difficult chapter that kept him away from matches for nearly five months. The absence stemmed from a pubalgia issue that required surgery on March 12, 2026, after persistent pain made it impossible for him to continue training normally.

Nayef Aguerd is officially cleared to play again, closing out a five-month absence caused by pubalgia surgery.

Following the operation, Aguerd went through a carefully structured recovery program. It began with complete rest, moved into physiotherapy sessions, then progressed to running work before he was allowed to touch a ball again. Each stage was designed to rebuild his physical condition without rushing the process. By April, he had returned to partial training, though the club made clear at the time that he was still far from ready for competitive action. Full integration with the group came at the end of July, setting up his eventual return this season. Aguerd has become known as a central figure in Morocco’s defensive rise, a reputation built through his performances for the Atlas Lions on the international stage, playing alongside fellow defender Jawad El Yamiq in a backline that has drawn praise for its solidity.

Genesio was careful to temper expectations despite the positive medical update. Speaking to reporters, he explained that Aguerd is physically fit but will need time to adjust to the intensity of match play after such a long layoff. The coach emphasized that priority will go to sensations, rhythm, and controlled reathleticization rather than throwing him straight into a starting role. He also said he intends to use the player as soon as circumstances allow, but only within the framework of a gradual reintegration plan.

This cautious approach reflects close coordination between the medical staff and the coaching team, both focused on limiting the risk of relapse. Aguerd remains a key figure in Marseille’s central defense, and his return adds valuable depth alongside Leo Balerdi, who has already resumed full training and competitive minutes. Together, the two give Genesio more tactical options at the back, particularly in build-up play where Aguerd’s composure on the ball has long been an asset.

For now, the plan is measured: manage his workload carefully, protect his fitness over the long season, and let him rediscover his best form step by step. Marseille appear willing to be patient, betting that a fully healthy Aguerd will pay dividends later.